Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Not applicableNo Longer AvailableNCT01980732What this trial is testing68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive TumorsWho this might be right forCarcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors Andrei Iagaru
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT00804336What this trial is testingPasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Ended earlyNCT05909995What this trial is testingInterventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsWho this might be right forMelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more Incyte Corporation 8
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT06485739What this trial is testingIrinotecan Liposomes for the Treatment of Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Tumors First Affiliated Hospital Xi'an Jiaotong University 20
Not applicableStudy completedNCT03858855What this trial is testingInhaled Essential Oil Effect on Common QOL Concerns During Cancer TreatmentWho this might be right forGastrointestinal CancerNeuroendocrine CarcinomaSkin Cancer Ohio State University Comprehensive Cancer Center 248
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT02307500What this trial is testingRegorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyWho this might be right forPancreas CancerOvarian CancerMelanoma+4 more Istituto Clinico Humanitas 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875What this trial is testingTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+4 more ECOG-ACRIN Cancer Research Group 144